CAS 36626-03-6

4-Aminoquinoline-3-carbonitrile

CAS : 36626-03-6

4-Aminoquinoline-3-carbonitrile is a butyronitrile derivative that is synthesized by reacting xylene with an amine. It has been shown to be active against chronic myeloid leukemia, lymphocytic leukemia, and chronic myeloid leukemia cells in vitro. The activity of 4-aminoquinoline-3-carbonitrile against these cancers may be due to its ability to inhibit the phosphotidylinositol 3 kinase and mammalian target of rapamycin signaling pathways. This drug also inhibits the activity of tyrosine protein kinases, including c-KIT, PDGFRA, and FGFR1. The most common side effect of 4-aminoquinoline-3-carbonitrile is a decrease in white blood cell count (neutropenia).

Formule : C₁₀H₇N₃

Degré de pureté : Min. 95%

Masse moléculaire : 169.18 g/mol

Ref: 3D-LBA62603